Company Information
CIN
Status
Date of Incorporation
06 May 1999
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
26 September 2023
Paid Up Capital
152,099,340
Authorised Capital
238,990,000
Directors
Sandeep A Naik
Director/Designated Partner
over 2 years ago
over 2 years ago
Shantanu Rastogi
Director/Designated Partner
over 2 years ago
over 2 years ago
Parag Suganchand Sancheti
Director/Designated Partner
almost 3 years ago
almost 3 years ago
Himanshu Nivsarkar
Nominee Director
almost 13 years ago
almost 13 years ago
Nitin Jagannath Deshmukh
Director
over 18 years ago
over 18 years ago
Past Directors
Varun Talukdar
Additional Director
over 2 years ago
over 2 years ago
Arjun Oberoi
Additional Director
about 7 years ago
about 7 years ago
Bangesh Chakrabarti
Director
almost 9 years ago
almost 9 years ago
Pratibha Sudhir Pilgaonkar
Director
over 25 years ago
over 25 years ago
Maharukh Tehmasp Rustomjee
Director
over 26 years ago
over 26 years ago
Sudhir Dhirendra Pilgaonkar
Director
over 26 years ago
over 26 years ago
Patents
An excipient from Trigonella foenum-graceum seeds and a process for preparation thereof is disclosed. The excipient
obtained from Trigonella foenum-graceum seeds, comprising insoluble and soluble dietary fibers can be used in various phar
maceutical or cosmetic compositions and food, nutritional or dietary prepara...
The present invention discloses compositions comprising fenugreek hydrocolloids comprising soluble and insoluble dietary fibers. The present invention further relates to the use of these compositions comprising fenugreek hydrocolloids as healthcare, personal care, food, household care and industrial products.
...
The present invention relates to a novel dispersible tablet composition, which comprises of a pharmacologically active ingredient and at least one excipient, which reduces the sedimentation rate of active ingredient. This invention further relates to a process for the preparation of a dispersible tablet of a pharmac...
The present invention relates to modified release compositions comprising multitude of modified release beads. The modified release beads comprise a matrix of at least one active ingredient at least one ion exchange resin at least one non polymeric multifunctional excipient; substantially coated with at least one ou...
The present invention relates to gastroretentive dosage forms of gamma aminobutyric acid ("GABA") analogs, and to processes for preparation of the same. The present invention provides gastroretentive dosage forms comprising GABA analog, at least one swelling agent and at least one non-swelling release retardant.
...
The present invention relates to oral care compositions and to method of maintaining oral health. The oral care composition of the present invention comprises at least one carbon dioxide source at least one acid source at least one abrasive and one or more pharmaceutically acceptable excipients.
...
The present invention relates to dietary fiber compositions comprising fenugreek dietary fibers. The present invention also relates to use of these compositions as dietary supplements, functional foods or pharmaceutical preparations for promoting satiety and weight loss. lowering cholesterol, controlling blood gluco...
The present invention provides a composition exhibiting delayed transit through the gastrointestinal tract comprising one or more active agents, fenugreek fiber and at least one pharmaceutically acceptable excipient. The present invention further relates to gastroretentive dosage forms comprising fenugreek fibers.
...
The present invention relates to controlled release pharmaceutical formulations of direct thrombin inhibitors and processes for preparing such compositions. Particularly the present invention relates to oral controlled release pharmaceutical compositions comprising dabigatran etexilate or pharmaceutically acceptable...
The present invention provides a controlled release formulation comprising an
therapeutically effective amount of vitamin C, at least glyceryl ester, and at least one
cellulose ether. The said dosage form provides substantially complete and controlled
release of the vitamin C with reduced initial burst release.
...
The novel sustained release dosage form comprising an active agent and a combination of a non-swelling pH dependent release retardant and a non swelling pH independent release retardant polymer which provides pH-independent drug release for a considerable period of time after administration.
A novel solvent free process of obtaining an insoluble fiber rich fraction from Trigonella Foenum-graecum seeds is disclosed. The multifunctional fiber rich fraction (FRF) and highly purified FRF are useful as excipients for pharmaceutical dosage forms for various routes of administration. These excipients can be us...
The present invention relates to the method of increasing the bioavailability of Angiotensin II Receptor Blockers (ARBs) by preparing a composition of an ARB with at least one solubility enhancing agent. In particular, the present invention relates to solubility enhancing agents that not only act as solubility enhan...
A directly compressible composite for an orally disintegrating tablet comprising at least one water-soluble excipient and calcium silicate prepared by co-processing.
The present invention relates to a novel dispersible tablet composition, which comprises of a pharmacologically active ingredient and at least one excipient, which reduces the sedimentation rate of active ingredient. This invention further relates to a process for the preparation of a dispersible tablet of a pharmac...
The present invention provides a controlled release formulation comprising an therapeutically effective amount of pharmacologically active substance having high water solubility, at least one non-polymeric release retardant, and at least one pH independent non-swelling release retarding polymer. The said dosage form...
The present invention relates to the methods of increasing the bioavailability of Angiotensin II Recptor Blockers (ARBs) by treating it with at least one absorption augmenting agent. In particular, the present invention relates to use of absorption augmenting agents which results in significant increase in the bioav...
Highly compressible controlled delivery compositions of metformin or salts thereof and the process of making the same are disclosed. Metformin is granulated with a binder and further dispersed in a rate-controlling matrix that results in increased hardness and decreased friability thereby effectively solving compres...
A novel solid oral dosage form comprising a therapeutically effective amount of hydrophobic pharmacological active ingredient and at least one particle separating agent preferably selected from a class of wetting agents, prepared without or with minimum amount of a disintegrating agent. The hydrophobic pharmacologic...
Sustained release compositions comprising plurality of sustained release beads are disclosed. Particularly the sustained release beads comprise coated drug resin complexes comprising drug resin complexes of at least one active agent and at least one ion exchange resin; coated with at least one release modifier.
...
The present invention relates to modified release compositions comprising plurality of modified release units. Particularly the modified release units comprise at least one anti Alzheimer s agent at least one ion exchange resin and at least one release modifier.
The present invention provides particulate delivery systems comprising plurality of particles comprising fenugreek gum and at least one pharmaceutically acceptable excipient. The particulate delivery systems of the present invention are used for the delivery of therapeutic immunologic or diagnostic agents and the li...
The present invention relates to oral modified release compositions comprising plurality of modified release matrix particles and at least one pharmaceutically acceptable excipient; wherein the modified release matrix particles comprise at least one active agent at least one release controlling agent and at least on...
The present invention relates to multiple unit extended release pharmaceutical compositions comprising plurality of modified release units wherein each unit comprises of an active agent core comprising at least one pharmaceutically active agent and at least one pharmaceutically acceptable excipient substantially coa...
The present invention is directed to a pharmaceutical formulation of esketamine for nasal administration. The present invention further relates to pharmaceutical formulations of esketamine delivered through unit-dose nasal spray devices. The invention also relates to a process for the preparation of such a compositi...
The present invention relates to modified release formulations of levodopa. Particularly the invention relates to modified release formulation of levodopa that offers reduced dosing frequency.
Registered Trademarks
[Class : 5] Pharmaceuticals And Medicinal Preparations
[Class : 42] Providing Scientific And Industrial Research, Research And Development, Technical Research, Medical Clinics, Quality Control, Testing And Services, In Vitro Bioequivalence Studies And Services, Nasal And Inhalation Product Development Research And Services, Drug Device Performance Testing And Services.
[Class : 5] Pharmaceuticals And Medicinal Preparations
View +43 more Brands for Rubicon Research Private Limited.
Charges
06 September 2018
Icici Bank Limited
28 Crore
29 January 2018
Axis Bank Limited
21 Lak
18 March 2016
Tjsb Sahakari Bank Limited
5 Crore
24 June 2013
Tjsb Sahakari Bank Limited
20 Lak
24 January 2013
Axis Bank Limited
23 Crore
19 December 2011
Tjsb Sahakari Bank Limited
8 Crore
14 December 2012
Tjsb Sahakari Bank Limited
3 Lak
18 March 2014
Tjsb Sahakari Bank Limited
14 Lak
14 August 2012
The Thane Janata Sahakari Bank Ltd
6 Lak
14 August 2012
The Thane Janata Sahakari Bank Ltd
4 Lak
22 December 2011
Tjsb Sahakati Bank Limited
5 Crore
19 December 2011
Tjsb Sahakari Bank Limited
5 Crore
25 May 2012
The Thane Janata Sahakari Bank Limited
17 Crore
17 December 2011
The Thane Janata Sahakari Bank Limited
4 Crore
28 December 2007
Bank Of India
18 Crore
28 December 2007
Bank Of India
12 Crore
30 June 2009
Bank Of India
8 Crore
07 October 2006
Dombivli Nagari Sahakari Bank Ltd.
75 Lak
11 July 2007
Dombivli Nagari Sahakari Bank Limited
40 Lak
05 May 2005
Dombivli Nagari Sahakari Bank Limited
66 Lak
26 July 2002
Dombivlo Nagari Sahakari Bank Ltd
31 Lak
22 August 2003
Dombivlo Nagari Sahakari Bank Ltd
7 Lak
12 December 2002
Dombivlo Nagari Sahakari Bank Ltd
4 Lak
21 March 2001
Dombivlo Nagari Sahakari Bank Ltd
49 Lak
21 August 2001
Dombivlo Nagari Sahakari Bank Ltd
3 Lak
01 October 2003
Dombivli Nagari Sahakari Bank Limited
10 Lak
01 October 2003
Dombivlo Nagari Sahakari Bank Ltd
30 Lak
12 August 2021
The Hongkong And Shanghai Banking Corporation Limited
73 Crore
30 June 2021
Hdfc Bank Limited
60 Crore
10 September 2020
The Hongkong And Shanghai Banking Corporation Limited
38 Crore
14 August 2020
The Hongkong And Shanghai Banking Corporation Limited
5 Crore
29 May 2020
Hdfc Bank Limited
93 Crore
21 August 2023
Dbs Bank Ltd
0
21 July 2023
Dbs Bank Ltd
0
09 December 2022
Axis Bank Limited
0
22 December 2022
Others
0
29 September 2022
Hdfc Bank Limited
0
08 February 2022
Hdfc Bank Limited
0
30 June 2021
Hdfc Bank Limited
0
29 May 2020
Hdfc Bank Limited
0
12 August 2021
The Hongkong And Shanghai Banking Corporation Limited
0
06 September 2018
Others
0
14 August 2020
The Hongkong And Shanghai Banking Corporation Limited
0
10 September 2020
The Hongkong And Shanghai Banking Corporation Limited
0
24 January 2013
Axis Bank Limited
0
18 March 2016
Tjsb Sahakari Bank Limited
0
01 October 2003
Dombivlo Nagari Sahakari Bank Ltd
0
30 June 2009
Bank Of India
0
21 August 2001
Dombivlo Nagari Sahakari Bank Ltd
0
05 May 2005
Dombivli Nagari Sahakari Bank Limited
0
14 August 2012
The Thane Janata Sahakari Bank Ltd
0
14 August 2012
The Thane Janata Sahakari Bank Ltd
0
22 December 2011
Tjsb Sahakati Bank Limited
0
19 December 2011
Tjsb Sahakari Bank Limited
0
19 December 2011
Tjsb Sahakari Bank Limited
0
28 December 2007
Bank Of India
0
22 August 2003
Dombivlo Nagari Sahakari Bank Ltd
0
26 July 2002
Dombivlo Nagari Sahakari Bank Ltd
0
14 December 2012
Tjsb Sahakari Bank Limited
0
29 January 2018
Axis Bank Limited
0
24 June 2013
Tjsb Sahakari Bank Limited
0
25 May 2012
The Thane Janata Sahakari Bank Limited
0
11 July 2007
Dombivli Nagari Sahakari Bank Limited
0
01 October 2003
Dombivli Nagari Sahakari Bank Limited
0
17 December 2011
The Thane Janata Sahakari Bank Limited
0
12 December 2002
Dombivlo Nagari Sahakari Bank Ltd
0
07 October 2006
Dombivli Nagari Sahakari Bank Ltd.
0
18 March 2014
Tjsb Sahakari Bank Limited
0
28 December 2007
Bank Of India
0
21 March 2001
Dombivlo Nagari Sahakari Bank Ltd
0
21 August 2023
Dbs Bank Ltd
0
21 July 2023
Dbs Bank Ltd
0
09 December 2022
Axis Bank Limited
0
22 December 2022
Others
0
29 September 2022
Hdfc Bank Limited
0
08 February 2022
Hdfc Bank Limited
0
30 June 2021
Hdfc Bank Limited
0
29 May 2020
Hdfc Bank Limited
0
12 August 2021
The Hongkong And Shanghai Banking Corporation Limited
0
06 September 2018
Others
0
14 August 2020
The Hongkong And Shanghai Banking Corporation Limited
0
10 September 2020
The Hongkong And Shanghai Banking Corporation Limited
0
24 January 2013
Axis Bank Limited
0
18 March 2016
Tjsb Sahakari Bank Limited
0
01 October 2003
Dombivlo Nagari Sahakari Bank Ltd
0
30 June 2009
Bank Of India
0
21 August 2001
Dombivlo Nagari Sahakari Bank Ltd
0
05 May 2005
Dombivli Nagari Sahakari Bank Limited
0
14 August 2012
The Thane Janata Sahakari Bank Ltd
0
14 August 2012
The Thane Janata Sahakari Bank Ltd
0
22 December 2011
Tjsb Sahakati Bank Limited
0
19 December 2011
Tjsb Sahakari Bank Limited
0
19 December 2011
Tjsb Sahakari Bank Limited
0
28 December 2007
Bank Of India
0
22 August 2003
Dombivlo Nagari Sahakari Bank Ltd
0
26 July 2002
Dombivlo Nagari Sahakari Bank Ltd
0
14 December 2012
Tjsb Sahakari Bank Limited
0
29 January 2018
Axis Bank Limited
0
24 June 2013
Tjsb Sahakari Bank Limited
0
25 May 2012
The Thane Janata Sahakari Bank Limited
0
11 July 2007
Dombivli Nagari Sahakari Bank Limited
0
01 October 2003
Dombivli Nagari Sahakari Bank Limited
0
17 December 2011
The Thane Janata Sahakari Bank Limited
0
12 December 2002
Dombivlo Nagari Sahakari Bank Ltd
0
07 October 2006
Dombivli Nagari Sahakari Bank Ltd.
0
18 March 2014
Tjsb Sahakari Bank Limited
0
28 December 2007
Bank Of India
0
21 March 2001
Dombivlo Nagari Sahakari Bank Ltd
0
Documents
Form ADT-1-10022021_signed
Form ADT-1-09012021_signed
Form MGT-6-09012021_signed
Form MGT-6-09012021_signed
-31122020
Copy of resolution passed by the company-30122020
Copy of written consent given by auditor-30122020
Form MSME FORM I-21122020_signed
Form ADT-3-18122020_signed
Resignation letter-17122020
Form CHG-1-18112020_signed
CERTIFICATE OF REGISTRATION OF CHARGE-20201118
Optional Attachment-(1)-17112020
Instrument(s) of creation or modification of charge;-17112020
Form DPT-3-12112020-signed
Form CHG-1-06102020_signed
CERTIFICATE OF REGISTRATION OF CHARGE-20201006
Instrument(s) of creation or modification of charge;-05102020
Form MSME FORM I-10092020_signed
Form DPT-3-10082020-signed
Letter of the charge holder stating that the amount has been satisfied-28072020
Form CHG-4-28072020_signed
CERTIFICATE OF SATISFACTION OF CHARGE-20200728
Form CHG-1-19062020_signed
Instrument(s) of creation or modification of charge;-19062020
Optional Attachment-(2)-19062020
Optional Attachment-(1)-19062020
CERTIFICATE OF REGISTRATION OF CHARGE-20200619
Letter of the charge holder stating that the amount has been satisfied-13052020
Form CHG-4-13052020_signed
